OYMotion

Company Profile

Founded in 2015 and headquartered in Zhangjiang Hi-Tech Park in Shanghai, China, OYMotion is a high-tech enterprise focusing on the cross-fertilization of brain science and robotics. With the brand vision of “Sense the Future”, OYMotion is committed to promoting the development of the future through the trinity of neural interfaces, robots and AI algorithms, which is an independent research and development platform.brain-computer interfacetogether withembodied intelligenceInnovation and development in the field. OmniTech has achieved remarkable results in the fields of intelligent bionic hand, dexterous hand, neuro-rehabilitation exoskeleton and brain-computer interface, and has become a leading enterprise in this field in China.

Closed a Series C1 financing round in March 2026, which was funded by theShenzhen Brain Science and Brain-like Intelligence Industry Investment Fund under CICC Capital.Omnicom is a subsidiary of Omnicom. Omnicom TechnologyCICC Brain Science Fund's first portfolio company, which had received investments from the actual controller of Sanbo Brain Group and Tianjin Heying Capital in 2023 and 2025, is currentlyThe only one in China to obtain the layout of two specialized brain science themed investment fundsThe company is a brain-computer interface enterprise. The company's shareholder lineup has been further upgraded, forming a dual strategic empowerment pattern of ”professional brain science fund + listed medical industry party”.

Products & Services

OYMotion's products and services are mainly centered on two major directions, Neurorehabilitation and Body Intelligence, which include:

1. Intelligent Bionic Hand (OHand™ Series)::
   • The FDA and CE certified smart bionic prosthetics have entered the international market and been included in the subsidized catalog of the Disabled Persons' Federation in many places.
   • Utilizing myoelectric signal decoding technology, it realizes multi-degree-of-freedom flexible manipulation and helps patients with limb dysfunction to recover fine movements such as grasping.
   • The product weighs only 530 grams, operates with an accuracy of 0.1 millimeters, has a response time of 0.8 seconds, and features 10 dexterous joints and 6 degrees of freedom.
   • The terminal selling price of 70,000-90,000 yuan is one-tenth of the price of imported products, which significantly reduces the cost of users.
2. Dexterous Hand (ROHand Series)::
   • Oriented to industrial and humanoid robot scenarios, it has realized batch supply and has been invited by Apple and other international enterprises for cooperation.
   • The second-generation dexterous hand ROH-AP001, introduced in 2025, integrates tactile sensors to sense subtle pressure changes from 0.1N to 25N in real time for greater adaptability.
   • ROH-LiteS001 is designed for small robots, weighing only 457g, with a whole hand load of 25kg and a repetitive positioning accuracy of ±0.1mm. Priced at RMB 8,888, it reinvents the benchmark for the industrial consumer-grade market.
3. Neurorehabilitation Exoskeleton (ORF Series)::
   • For the recovery of limb function in patients with stroke and spinal cord injury, the rehabilitation process is accelerated through precise motor assistance and neurofeedback training.
   • Neurorehabilitation ORF series products have been approved to enter the special approval channel for innovative medical devices in Shanghai in 2024 and are expected to be officially launched in 2026.
4. brain-computer interface (BCI) products::
   • Includes basic medical equipment such as smart EEG machines for the acquisition and decoding of neural signals to help patients with motor dysfunction perform specific movements.
   • Our products have been certified by FDA and FCC, and our sales cover the United States, the Middle East, Russia, Ukraine, India and many other countries and regions around the world.
5. Intelligent Rehabilitation Solutions::
   • Provides a complete solution from neural signal acquisition, AI algorithm parsing to execution by rehabilitation robots, providing a high-performance and low-cost neural interaction infrastructure for the field of neurorehabilitation.

core technology

OYMotion's core technology has built a trinity of independent R&D platform of “Neural Interface - Robotics - AI Algorithm”, which mainly includes:

1. Neural Signal Sensing and Decoding::
   • Specialized in human bioelectric sensor technology, biosignal AI pattern recognition algorithms, and EMG and EEG human-computer interaction core technologies.
   • The self-developed multi-channel EMG sensor array can simultaneously collect 16-channel EMG signals, combined with deep learning algorithms to achieve precise recognition of gesture intent, with an accuracy rate of over 98%.
2. Medical-grade neural interaction infrastructure::
   • Based on the self-developed brain/muscle-computer interface technology, we have created a basic hardware and software integration platform serving the fields of neurological rehabilitation and diagnosis.
3. Robotics::
   • Focusing on dexterous hand and bionic hand R&D, it adopts a rigid structural solution of motor + linkage to achieve ±1mm repetitive positioning accuracy.
   • With high degree of freedom, high load capacity and precise manipulation, Dexterous Hand products are suitable for a wide range of industrial and humanoid robotics scenarios.
4. AI algorithm::
   • Combining time-frequency domain features with texture features (e.g., cyclic grayscale covariance matrix) to optimize surface EMG signal processing and enhance robustness.
   • The real-time closed loop of EEG intent recognition, EMG motion decoding and robot execution feedback realizes the seamless conversion of neural commands to precise movements.

major client

1. Medical Rehabilitation Organization::
   • It cooperates with more than 150 domestic and foreign prosthetic rehabilitation centers and serves nearly 10,000 users.
   • The product has entered the subsidized catalog of China Disabled Persons' Federation, and users in Shanghai can reimburse the cost of 90%.
2. Embodied Intelligence Enterprise::
   • Became the core supplier of many domestic head-figure robot manufacturers, ROHand dexterous hand series became the standard configuration of the core model.
   • There are already more than 200 downstream customers, including well-known companies such as Zhiyuan Robotics and Feixi Technology.
3. international enterprise::
   • Obtaining the procurement intention of Apple and other technology giants, the products have obvious competitiveness in the European and American markets.
   • Intelligent bionic hand and non-invasive brain-computer interface products have realized overseas sales, covering the United States, the Middle East, Russia, Ukraine, India and many other countries and regions around the world.

development prospect

OYMotion has a broad development prospect in the field of brain-computer interface and embodied intelligence, which is mainly reflected in the following aspects:

1. Technology Innovation and Product Iteration::
   • Continuously invest in R&D to promote innovation and breakthroughs in core technologies such as neural interfaces, robotics and AI algorithms.
   • Continuously improve the product matrix to meet diversified needs in different scenarios and enhance market competitiveness.
2. Market Expansion and Internationalization::
   • Attaching great importance to the construction of overseas channels, actively expanding the international market and enhancing the global influence of our products.
   • Through cooperation with internationally renowned companies, we will jointly promote the globalization of brain-computer interface and embodied intelligence technology.
3. Commercialization and strategy development::
   • Formed a complete closed loop of “R & D - production - sales”, the performance of the past three years have doubled growth.
   • Establishing strategic partnerships with listed companies such as Radiodetection, and jointly sprinting for the trillion-dollar valuation track of Body Intelligence.
4. Policy Support and Industry Trends::
   • Benefit from the national policy support for brain science and brain-like intelligence industry, and the rapid growth of the global brain-computer interface and robotics market.
   • Seize the technology attack stage in the pre-breakout period of the industry, layout in advance and occupy the first market opportunity.